SCHEMBL21290410

SCHEMBL21290410

OOC1CCCc2cc(Oc3ccccc3)ccc21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4C Q9H3R0 2/20 0.46
HRH3 Q9Y5N1 1/20 0.46
IDO1 P14902 2/20 0.42
P2RX3 P56373 2/20 0.40
P2RX2 Q9UBL9 2/20 0.40
PKM P14618 1/20 0.40
PDE4A P27815 1/20 0.40
PDE4B Q07343 1/20 0.40
PDE4C Q08493 1/20 0.40
PDE4D Q08499 1/20 0.40
TAOK1 Q7L7X3 1/20 0.39
TAOK3 Q9H2K8 1/20 0.39
PPARD Q03181 2/20 0.39
NPC1 O15118 1/20 0.39
UCHL1 P09936 1/20 0.38
IGF1R P08069 1/20 0.38
ALOX15 P16050 1/20 0.38
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19278632 0.79 HRH3 (0.48) KDM4CHRH3P2RX3P2RX2PKM
SCHEMBL9489556 0.79 TAOK1 (0.48) KDM4CHRH3PKMPDE4APDE4B
SCHEMBL19278357 0.79 KDM4C (0.55) KDM4CHRH3PPARD
SCHEMBL21290402 0.77 HRH3 (0.42) KDM4CHRH3IDO1P2RX3P2RX2
SCHEMBL298463 0.76 IDO1 (0.68) IDO1ALDH1A1
SCHEMBL31235704 0.76 IDO1 (0.68) IDO1ALDH1A1
SCHEMBL15839880 0.76 HTR6 (0.61) KDM4CHRH3
SCHEMBL1744975 0.76 HRH3 (0.47) KDM4CHRH3PDE4APDE4BPDE4C
SCHEMBL31613068 0.74 KDM4C (0.48) KDM4CHRH3P2RX3P2RX2PKM
SCHEMBL9490649 0.73 P2RX3 (0.49) P2RX3P2RX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190256509-A1 HISTONE DEMETHYLASE INHIBITORS CHRYSALIS INC (US) 2019-08-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190256509-A1 HISTONE DEMETHYLASE INHIBITORS KDM1B, KDM6B, KDM2A KDM4C 20/4885HRH3 1029/4885IDO1 1251/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.